COMPANY

Claret Bioscience

Location: Santa Cruz, CA · source · Oct 15, 2026

Profile checked Oct 10, 2026

Funding and NIH signals

NIH award NIH awarded $386K (SBIR Phase I 1R43CA314763-01, new, notice Sep 17, 2026). NIH RePORTER 1R43CA314763-01 (Sep 17, 2026)
Evidence (1 event)
- Sep 17, 2026 · NIH RePORTER 1R43CA314763-01
  Organization: CLARET BIOSCIENCE, LLC; City/State: BIRMINGHAM, MI; Project number: 1R43CA314763-01; Activity code: R43; Fiscal year: 2026; Award notice date: 2026-09-17; FY total cost (award amount): 385919; Administering IC: National Cancer Institute; Project title: A cfDNA methylo-fragmentomic assay for prediction of risk-progression in Prostate Cancer; Organization type: Domestic For-Profits

Job counts as of Oct 18, 2026. All funding and NIH signals

Sep 17, 2026 Grant Government grant — SBIR: $385,919 (annual award, as published), announced Sep 17, 2026. Agency: NIH/NCI. Source: government award database. source ↗

Last 2 years.

Sep 17, 2026 Government grant — SBIR: $385,919 (annual award, as published), announced Sep 17, 2026. Agency: NIH/NCI. Source: government award database. source ↗